← FDA DRUG APPROVALS

FDA ANDA · ANDA202755

TRANEXAMIC ACID

Sponsor: CHARTWELL RX

APPLICATION
ANDA202755
TYPE
ANDA
ORIGINAL APPROVAL
2016-02-25
LATEST ACTION
2021-04-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TRANEXAMIC ACIDDiscontinued
TRANEXAMIC ACID 100MG/ML · INJECTABLE · INJECTION

Approval history

2021-04-14Labeling · Supplement 4 · standardAP
2020-11-18Labeling · Supplement 3 · standardAP
2018-09-12Manufacturing (CMC) · Supplement 1 · unknownAP
2016-02-25UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →